ReePrime
Blog DMC
Janssen (Johnson & Johnson) Must Pay $70 Million In Risperdal Case

Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.

Janssen (Johnson & Johnson) Must Pay $70 Million In Risperdal Case

H
Healthfeednews

19 Views • Jul 25, 2016

Description

A U.S. jury on Friday awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal. The jury in the Philadelphia Court of Common Pleas found that the company failed to warn the boy's healthcare providers about the risk of gynecomastia and that it intentionally falsified, destroyed, or concealed evidence in the case.

Keywords & Tags

#insurance #trump #domesticNews #business #Johnson Johnson #health insurance #financial #health #Reuters #Haloperidol #pharmaceuticals #Court #Jury #obamacare #Janssen #gynecomastia #Antipsychotic #JohnsonJohnson #Risperidone #medical device #Janssen Pharmaceuticals

More from User

01:32

Ten Healthiest Small Cities in the U.S.

Healthfeednews

00:36

Obamacare had over 11.5 Million Registrations

Healthfeednews

00:43

Study Says 17 Million US Adults Have 'Hidden' High Blood Pressure

Healthfeednews

00:54

Trump's Controversial Appointments For Healthcare

Healthfeednews

01:22

Reasons to Buy Generic Drugs Instead of Brand-Name

Healthfeednews

00:57

FDA's New Drug Approvals Fall to Six Year Low

Healthfeednews

Related Videos

00:54

Janssen (Johnson & Johnson) Must Pay $70 Million In Risperdal Case

HealthFeed

01:58

Clinical trial ng Janssen Pharmaceuticals sa bansa, nagsimula na

PTVPhilippines

04:16

Clinical trial ng COVID-19 vaccine ng Janssen Pharmaceuticals, magsisimula na ngayong linggo

PTVPhilippines

02:10

Janssen Pharmaceuticals starts COVID-19 vaccine clinical trials in PH

PTVPhilippines

04:02

IP Pharmaceuticals and Public Health

Phillip Taylor

00:08

Read Pharmaceuticals Corporate Crime and Public Health Ebook Online

Meeli Kuusk